N-[(1-benzyl-3,5-dimethylpyrazol-4-yl)methyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(3-chloro-5-methyl-2-pyridinyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(2-cyclopentylpyrazol-3-yl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-cyclopropyl-2-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]benzamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-[[2-(morpholin-4-ylmethyl)phenyl]methyl]acetamide

C94H107ClN32O17 — CID 123975768

IUPACN-[(1-benzyl-3,5-dimethylpyrazol-4-yl)methyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(3-chloro-5-methyl-2-pyridinyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(2-cyclopentylpyrazol-3-yl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-cyclopropyl-2-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]benzamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-[[2-(morpholin-4-ylmethyl)phenyl]methyl]acetamide
SMILESCc1cnc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)c(Cl)c1.Cc1nn(Cc2ccccc2)c(C)c1CNC(=O)Cn1cnc2c1c(=O)n(C)c(=O)n2C.Cn1c(=O)c2c(ncn2CC(=O)NCc2ccccc2CN2CCOCC2)n(C)c1=O.Cn1c(=O)c2c(ncn2CC(=O)Nc2ccccc2C(=O)NC2CC2)n(C)c1=O.Cn1c(=O)c2c(ncn2CC(=O)Nc2ccnn2C2CCCC2)n(C)c1=O
InChIInChI=1S/C22H25N7O3.C21H26N6O4.C19H20N6O4.C17H21N7O3.C15H15ClN6O3/c1-14-17(15(2)29(25-14)11-16-8-6-5-7-9-16)10-23-18(30)12-28-13-24-20-19(28)21(31)27(4)22(32)26(20)3;1-24-19-18(20(29)25(2)21(24)30)27(14-23-19)13-17(28)22-11-15-5-3-4-6-16(15)12-26-7-9-31-10-8-26;1-23-16-15(18(28)24(2)19(23)29)25(10-20-16)9-14(26)22-13-6-4-3-5-12(13)17(27)21-11-7-8-11;1-21-15-14(16(26)22(2)17(21)27)23(10-18-15)9-13(25)20-12-7-8-19-24(12)11-5-3-4-6-11;1-8-4-9(16)12(17-5-8)19-10(23)6-22-7-18-13-11(22)14(24)21(3)15(25)20(13)2/h5-9,13H,10-12H2,1-4H3,(H,23,30);3-6,14H,7-13H2,1-2H3,(H,22,28);3-6,10-11H,7-9H2,1-2H3,(H,21,27)(H,22,26);7-8,10-11H,3-6,9H2,1-2H3,(H,20,25);4-5,7H,6H2,1-3H3,(H,17,19,23)
InChIKeyRSUZHBKFUYTOFS-UHFFFAOYSA-N
MW1992.55 g/mol
LogP0.97
Rot. Bonds24

About N-[(1-benzyl-3,5-dimethylpyrazol-4-yl)methyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(3-chloro-5-methyl-2-pyridinyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(2-cyclopentylpyrazol-3-yl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-cyclopropyl-2-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]benzamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-[[2-(morpholin-4-ylmethyl)phenyl]methyl]acetamide

N-[(1-benzyl-3,5-dimethylpyrazol-4-yl)methyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(3-chloro-5-methyl-2-pyridinyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(2-cyclopentylpyrazol-3-yl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-cyclopropyl-2-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]benzamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-[[2-(morpholin-4-ylmethyl)phenyl]methyl]acetamide (PubChem CID 123975768) has the molecular formula C94H107ClN32O17 and a molecular weight of 1992.55 g/mol. Its IUPAC name is N-[(1-benzyl-3,5-dimethylpyrazol-4-yl)methyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(3-chloro-5-methyl-2-pyridinyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(2-cyclopentylpyrazol-3-yl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-cyclopropyl-2-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]benzamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-[[2-(morpholin-4-ylmethyl)phenyl]methyl]acetamide.

Molecular Properties

Compound NameN-[(1-benzyl-3,5-dimethylpyrazol-4-yl)methyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(3-chloro-5-methyl-2-pyridinyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(2-cyclopentylpyrazol-3-yl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-cyclopropyl-2-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]benzamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-[[2-(morpholin-4-ylmethyl)phenyl]methyl]acetamide
PubChem CID123975768
Molecular FormulaC94H107ClN32O17
Molecular Weight1992.55 g/mol
Exact Mass1990.82
IUPAC NameN-[(1-benzyl-3,5-dimethylpyrazol-4-yl)methyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(3-chloro-5-methyl-2-pyridinyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(2-cyclopentylpyrazol-3-yl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-cyclopropyl-2-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]benzamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-[[2-(morpholin-4-ylmethyl)phenyl]methyl]acetamide
SMILESCc1cnc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)c(Cl)c1.Cc1nn(Cc2ccccc2)c(C)c1CNC(=O)Cn1cnc2c1c(=O)n(C)c(=O)n2C.Cn1c(=O)c2c(ncn2CC(=O)NCc2ccccc2CN2CCOCC2)n(C)c1=O.Cn1c(=O)c2c(ncn2CC(=O)Nc2ccccc2C(=O)NC2CC2)n(C)c1=O.Cn1c(=O)c2c(ncn2CC(=O)Nc2ccnn2C2CCCC2)n(C)c1=O
InChIInChI=1S/C22H25N7O3.C21H26N6O4.C19H20N6O4.C17H21N7O3.C15H15ClN6O3/c1-14-17(15(2)29(25-14)11-16-8-6-5-7-9-16)10-23-18(30)12-28-13-24-20-19(28)21(31)27(4)22(32)26(20)3;1-24-19-18(20(29)25(2)21(24)30)27(14-23-19)13-17(28)22-11-15-5-3-4-6-16(15)12-26-7-9-31-10-8-26;1-23-16-15(18(28)24(2)19(23)29)25(10-20-16)9-14(26)22-13-6-4-3-5-12(13)17(27)21-11-7-8-11;1-21-15-14(16(26)22(2)17(21)27)23(10-18-15)9-13(25)20-12-7-8-19-24(12)11-5-3-4-6-11;1-8-4-9(16)12(17-5-8)19-10(23)6-22-7-18-13-11(22)14(24)21(3)15(25)20(13)2/h5-9,13H,10-12H2,1-4H3,(H,23,30);3-6,14H,7-13H2,1-2H3,(H,22,28);3-6,10-11H,7-9H2,1-2H3,(H,21,27)(H,22,26);7-8,10-11H,3-6,9H2,1-2H3,(H,20,25);4-5,7H,6H2,1-3H3,(H,17,19,23)
InChIKeyRSUZHBKFUYTOFS-UHFFFAOYSA-N
XLogP0.97
TPSA544.70 Ų
H-Bond Donors6
H-Bond Acceptors43
Rotatable Bonds24
Heavy Atoms144
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001992.55
LogP ≤ 50.97
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1043

Analyze N-[(1-benzyl-3,5-dimethylpyrazol-4-yl)methyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(3-chloro-5-methyl-2-pyridinyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(2-cyclopentylpyrazol-3-yl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-cyclopropyl-2-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]benzamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-[[2-(morpholin-4-ylmethyl)phenyl]methyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(1-benzyl-3,5-dimethylpyrazol-4-yl)methyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(3-chloro-5-methyl-2-pyridinyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(2-cyclopentylpyrazol-3-yl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-cyclopropyl-2-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]benzamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-[[2-(morpholin-4-ylmethyl)phenyl]methyl]acetamide?
The IUPAC name of N-[(1-benzyl-3,5-dimethylpyrazol-4-yl)methyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(3-chloro-5-methyl-2-pyridinyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(2-cyclopentylpyrazol-3-yl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-cyclopropyl-2-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]benzamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-[[2-(morpholin-4-ylmethyl)phenyl]methyl]acetamide (CID 123975768) is N-[(1-benzyl-3,5-dimethylpyrazol-4-yl)methyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(3-chloro-5-methyl-2-pyridinyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(2-cyclopentylpyrazol-3-yl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-cyclopropyl-2-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]benzamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-[[2-(morpholin-4-ylmethyl)phenyl]methyl]acetamide.
What is the SMILES notation for N-[(1-benzyl-3,5-dimethylpyrazol-4-yl)methyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(3-chloro-5-methyl-2-pyridinyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(2-cyclopentylpyrazol-3-yl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-cyclopropyl-2-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]benzamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-[[2-(morpholin-4-ylmethyl)phenyl]methyl]acetamide?
The canonical SMILES for N-[(1-benzyl-3,5-dimethylpyrazol-4-yl)methyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(3-chloro-5-methyl-2-pyridinyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(2-cyclopentylpyrazol-3-yl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-cyclopropyl-2-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]benzamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-[[2-(morpholin-4-ylmethyl)phenyl]methyl]acetamide is Cc1cnc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)c(Cl)c1.Cc1nn(Cc2ccccc2)c(C)c1CNC(=O)Cn1cnc2c1c(=O)n(C)c(=O)n2C.Cn1c(=O)c2c(ncn2CC(=O)NCc2ccccc2CN2CCOCC2)n(C)c1=O.Cn1c(=O)c2c(ncn2CC(=O)Nc2ccccc2C(=O)NC2CC2)n(C)c1=O.Cn1c(=O)c2c(ncn2CC(=O)Nc2ccnn2C2CCCC2)n(C)c1=O.
What is the InChIKey of N-[(1-benzyl-3,5-dimethylpyrazol-4-yl)methyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(3-chloro-5-methyl-2-pyridinyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(2-cyclopentylpyrazol-3-yl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-cyclopropyl-2-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]benzamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-[[2-(morpholin-4-ylmethyl)phenyl]methyl]acetamide?
The InChIKey is RSUZHBKFUYTOFS-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H25N7O3.C21H26N6O4.C19H20N6O4.C17H21N7O3.C15H15ClN6O3/c1-14-17(15(2)29(25-14)11-16-8-6-5-7-9-16)10-23-18(30)12-28-13-24-20-19(28)21(31)27(4)22(32)26(20)3;1-24-19-18(20(29)25(2)21(24)30)27(14-23-19)13-17(28)22-11-15-5-3-4-6-16(15)12-26-7-9-31-10-8-26;1-23-16-15(18(28)24(2)19(23)29)25(10-20-16)9-14(26)22-13-6-4-3-5-12(13)17(27)21-11-7-8-11;1-21-15-14(16(26)22(2)17(21)27)23(10-18-15)9-13(25)20-12-7-8-19-24(12)11-5-3-4-6-11;1-8-4-9(16)12(17-5-8)19-10(23)6-22-7-18-13-11(22)14(24)21(3)15(25)20(13)2/h5-9,13H,10-12H2,1-4H3,(H,23,30);3-6,14H,7-13H2,1-2H3,(H,22,28);3-6,10-11H,7-9H2,1-2H3,(H,21,27)(H,22,26);7-8,10-11H,3-6,9H2,1-2H3,(H,20,25);4-5,7H,6H2,1-3H3,(H,17,19,23).
What are the key properties of N-[(1-benzyl-3,5-dimethylpyrazol-4-yl)methyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(3-chloro-5-methyl-2-pyridinyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(2-cyclopentylpyrazol-3-yl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-cyclopropyl-2-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]benzamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-[[2-(morpholin-4-ylmethyl)phenyl]methyl]acetamide?
N-[(1-benzyl-3,5-dimethylpyrazol-4-yl)methyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(3-chloro-5-methyl-2-pyridinyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(2-cyclopentylpyrazol-3-yl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-cyclopropyl-2-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]benzamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-[[2-(morpholin-4-ylmethyl)phenyl]methyl]acetamide has a molecular weight of 1992.55 g/mol, XLogP of 0.97, 24 rotatable bonds, 6 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1-benzyl-3,5-dimethylpyrazol-4-yl)methyl]-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(3-chloro-5-methyl-2-pyridinyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-(2-cyclopentylpyrazol-3-yl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-cyclopropyl-2-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]benzamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-[[2-(morpholin-4-ylmethyl)phenyl]methyl]acetamide is sourced from PubChem (CID 123975768), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).